1-4 of 4
Pierre Sérusclat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

Optimizing Basal-Bolus Therapy in T2D—A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch vs. an Insulin Pen

RICHARD M. BERGENSTAL, MARK PEYROT, DARLENE M. DREON, VANITA ARODA, TIMOTHY S. BAILEY, RONALD L. BRAZG, JUAN P. FRIAS, MARY L. JOHNSON, DAVID C. KLONOFF, DAVIDA F. KRUGER, SHENAZ RAMTOOLA, JULIO ROSENSTOCK, PIERRE SERUSCLAT, RUTH S. WEINSTOCK, RAMACHANDRA G. NAIK, DAVID M. SHEARER, VIVIEN ZRAICK, BRIAN L. LEVY
Journal: Diabetes
Diabetes 2018;67(Supplement_1):987-P
https://doi.org/10.2337/db18-987-P
Published: 01 July 2018
View article titled, Optimizing Basal-Bolus Therapy in T2D—A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch vs. an Insulin Pen
Meeting Abstracts

User- and Health Care Provider–Reported Outcomes for a Wearable Bolus Insulin Delivery Patch

MARK PEYROT, RICHARD M. BERGENSTAL, DARLENE M. DREON, VANITA ARODA, TIMOTHY S. BAILEY, RONALD L. BRAZG, JUAN P. FRIAS, MARY L. JOHNSON, DAVID C. KLONOFF, DAVIDA F. KRUGER, SHENAZ RAMTOOLA, JULIO ROSENSTOCK, PIERRE SERUSCLAT, RUTH S. WEINSTOCK, RAMACHANDRA G. NAIK, DAVID M. SHEARER, VIVIEN ZRAICK, BRIAN L. LEVY
Journal: Diabetes
Diabetes 2018;67(Supplement_1):995-P
https://doi.org/10.2337/db18-995-P
Published: 01 July 2018
View article titled, User- and Health Care Provider–Reported Outcomes for a Wearable Bolus Insulin Delivery Patch
Meeting Abstracts

Patients with Type 2 Diabetes (T2D) on the Maximum Dose of Insulin Degludec/Liraglutide (IDegLira) Achieve Glycemic Target—Analyses from the DUAL Program

LUIGI MENEGHINI, SULTAN LINJAWI, PIERRE SERUSCLAT, TINA VILSBØLL, BUE F. AGNER, TRINE HANSEN, LAWRENCE A. LEITER
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1109-P
https://doi.org/10.2337/db18-1109-P
Published: 01 July 2018
View article titled, Patients with Type 2 Diabetes (T2D) on the Maximum Dose of Insulin Degludec/Liraglutide (IDegLira) Achieve Glycemic Target—Analyses from the DUAL Program
Journal Articles

Mononuclear Leukocyte β2-Adrenergic Receptors and Adenylate Cyclase Sensitivity in Insulin-dependent Diabetes Mellitus

Pierre Sérusclat, Stephen G Rosen, Edward B Smith, Suresh D Shah, William E Clutter, Philip E Cryer
Journal: Diabetes
Diabetes 1983;32(9):825–829
https://doi.org/10.2337/diab.32.9.825
Published: 01 September 1983
View article titled, Mononuclear Leukocyte β<sub>2</sub>-Adrenergic Receptors and Adenylate Cyclase Sensitivity in Insulin-dependent Diabetes Mellitus
Open the PDF for Mononuclear Leukocyte β<sub>2</sub>-Adrenergic Receptors and Adenylate Cyclase Sensitivity in Insulin-dependent Diabetes Mellitus in another window